Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01

FDA recall notice · announced August 18, 2021 · Eli Lilly &

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01

Reason for recall

cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.

Notes

Distribution: OH, MS, IN
Lot/code information: Lot # 197
Quantity: 36,540 vials
Status: Terminated
Products in this recall event:
- Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01 (D-0720-2021)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.